Cargando…
Selected by bioinformatics and molecular docking analysis, Dhea and 2–14,15-Eg are effective against cholangiocarcinoma
OBJECT: To identify novel targets for the diagnosis, treatment and prognosis of cholangiocarcinoma, we screen ideal lead compounds and preclinical drug candidates with MYC inhibitory effect from the ZINC database, and verify the therapeutic effect of Dhea and 2–14,15-Eg on cholangiocarcinoma. METHOD...
Autores principales: | Qin, Lei, Kuai, Jun, Yang, Fang, Yang, Lu, Sun, Peisheng, Zhang, Lanfang, Li, Guangpeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812988/ https://www.ncbi.nlm.nih.gov/pubmed/35113866 http://dx.doi.org/10.1371/journal.pone.0260180 |
Ejemplares similares
-
14,15-Didehydrohellebrigenin
por: Yu, Tong, et al.
Publicado: (2012) -
14,15-Epoxyeicosa-5,8,11-trienoic
Acid (14,15-EET)
Surrogates: Carboxylate Modifications
por: Falck, John R., et al.
Publicado: (2014) -
Correction to 14,15-Epoxyeicosa-5,8,11-trienoic
Acid (14,15-EET) Surrogates: Carboxylate Modifications
por: Falck, John R., et al.
Publicado: (2014) -
15-Methoxy-14,15-dihydroandranginine
por: Wang, Dian-Lei, et al.
Publicado: (2013) -
The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins
por: Yang, Tian, et al.
Publicado: (2013)